vs
Side-by-side financial comparison of FARMERS NATIONAL BANC CORP (FMNB) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
FARMERS NATIONAL BANC CORP is the larger business by last-quarter revenue ($71.5M vs $39.6M, roughly 1.8× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 20.5%, a 15.4% gap on every dollar of revenue. On growth, FARMERS NATIONAL BANC CORP posted the faster year-over-year revenue change (3.2% vs -10.9%). FARMERS NATIONAL BANC CORP produced more free cash flow last quarter ($52.2M vs $51.2M). Over the past eight quarters, FARMERS NATIONAL BANC CORP's revenue compounded faster (6.2% CAGR vs -15.0%).
Farmers National Banc Corp (OH) is a regional financial holding company based in Ohio, the United States. It offers full-spectrum retail and commercial banking products, wealth management solutions, and insurance services, primarily catering to individual consumers, small and medium-sized enterprises, and local community clients in Ohio and adjacent Midwestern U.S. regions.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
FMNB vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $71.5M | $39.6M |
| Net Profit | $14.6M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | 24.8% | 32.5% |
| Net Margin | 20.5% | 35.9% |
| Revenue YoY | 3.2% | -10.9% |
| Net Profit YoY | 1.7% | 117.2% |
| EPS (diluted) | $0.39 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $71.5M | $39.6M | ||
| Q3 25 | $70.8M | $43.4M | ||
| Q2 25 | $69.8M | $43.4M | ||
| Q1 25 | $67.8M | $47.3M | ||
| Q4 24 | $69.3M | $44.4M | ||
| Q3 24 | $70.3M | $53.1M | ||
| Q2 24 | $66.5M | $53.1M | ||
| Q1 24 | $63.4M | $54.8M |
| Q4 25 | $14.6M | $14.2M | ||
| Q3 25 | $12.5M | $12.8M | ||
| Q2 25 | $13.9M | $2.5M | ||
| Q1 25 | $13.6M | $21.5M | ||
| Q4 24 | $14.4M | $6.5M | ||
| Q3 24 | $8.5M | $2.8M | ||
| Q2 24 | $11.8M | $18.5M | ||
| Q1 24 | $11.2M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 24.8% | 32.5% | ||
| Q3 25 | 20.7% | 36.6% | ||
| Q2 25 | 23.4% | 33.6% | ||
| Q1 25 | 24.1% | 51.1% | ||
| Q4 24 | 25.5% | 10.6% | ||
| Q3 24 | 14.4% | 26.1% | ||
| Q2 24 | 21.3% | 51.4% | ||
| Q1 24 | 21.2% | 44.6% |
| Q4 25 | 20.5% | 35.9% | ||
| Q3 25 | 17.6% | 29.6% | ||
| Q2 25 | 19.9% | 5.7% | ||
| Q1 25 | 20.0% | 45.4% | ||
| Q4 24 | 20.8% | 14.7% | ||
| Q3 24 | 12.1% | 5.3% | ||
| Q2 24 | 17.7% | 34.8% | ||
| Q1 24 | 17.7% | 34.2% |
| Q4 25 | $0.39 | $0.15 | ||
| Q3 25 | $0.33 | $0.12 | ||
| Q2 25 | $0.37 | $0.02 | ||
| Q1 25 | $0.36 | $0.21 | ||
| Q4 24 | $0.38 | $0.05 | ||
| Q3 24 | $0.23 | $0.03 | ||
| Q2 24 | $0.31 | $0.20 | ||
| Q1 24 | $0.30 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $164.1M |
| Total DebtLower is stronger | $86.7M | $42.8M |
| Stockholders' EquityBook value | $485.7M | $248.3M |
| Total Assets | $5.2B | $380.4M |
| Debt / EquityLower = less leverage | 0.18× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $164.1M | ||
| Q3 25 | — | $127.4M | ||
| Q2 25 | — | $152.7M | ||
| Q1 25 | — | $132.1M | ||
| Q4 24 | — | $125.0M | ||
| Q3 24 | — | $137.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $86.7M | $42.8M | ||
| Q3 25 | $86.6M | $21.1M | ||
| Q2 25 | $86.4M | $7.1M | ||
| Q1 25 | $86.3M | $6.9M | ||
| Q4 24 | $86.2M | $6.6M | ||
| Q3 24 | $86.0M | $823.2K | ||
| Q2 24 | $88.9M | — | ||
| Q1 24 | $88.8M | — |
| Q4 25 | $485.7M | $248.3M | ||
| Q3 25 | $465.9M | $248.0M | ||
| Q2 25 | $437.7M | $244.6M | ||
| Q1 25 | $429.1M | $226.4M | ||
| Q4 24 | $406.0M | $195.1M | ||
| Q3 24 | $439.7M | $205.0M | ||
| Q2 24 | $396.7M | $8.8M | ||
| Q1 24 | $397.0M | $9.0M |
| Q4 25 | $5.2B | $380.4M | ||
| Q3 25 | $5.2B | $321.4M | ||
| Q2 25 | $5.2B | $315.3M | ||
| Q1 25 | $5.2B | $284.6M | ||
| Q4 24 | $5.1B | $266.1M | ||
| Q3 24 | $5.2B | $296.5M | ||
| Q2 24 | $5.2B | $19.5M | ||
| Q1 24 | $5.1B | $19.8M |
| Q4 25 | 0.18× | 0.17× | ||
| Q3 25 | 0.19× | 0.09× | ||
| Q2 25 | 0.20× | 0.03× | ||
| Q1 25 | 0.20× | 0.03× | ||
| Q4 24 | 0.21× | 0.03× | ||
| Q3 24 | 0.20× | 0.00× | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.22× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $60.0M | $52.0M |
| Free Cash FlowOCF − Capex | $52.2M | $51.2M |
| FCF MarginFCF / Revenue | 73.0% | 129.3% |
| Capex IntensityCapex / Revenue | 11.0% | 2.0% |
| Cash ConversionOCF / Net Profit | 4.10× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $85.8M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.0M | $52.0M | ||
| Q3 25 | $10.7M | $-20.9M | ||
| Q2 25 | $14.0M | $-8.3M | ||
| Q1 25 | $15.7M | $1.9M | ||
| Q4 24 | $66.6M | $-7.3M | ||
| Q3 24 | $23.9M | $5.0M | ||
| Q2 24 | $16.6M | $19.2M | ||
| Q1 24 | $13.7M | $3.7M |
| Q4 25 | $52.2M | $51.2M | ||
| Q3 25 | $9.0M | $-20.9M | ||
| Q2 25 | $12.4M | $-8.6M | ||
| Q1 25 | $12.2M | $1.7M | ||
| Q4 24 | $54.9M | $-7.9M | ||
| Q3 24 | $20.4M | $4.6M | ||
| Q2 24 | $14.4M | $18.3M | ||
| Q1 24 | $12.2M | $3.0M |
| Q4 25 | 73.0% | 129.3% | ||
| Q3 25 | 12.8% | -48.3% | ||
| Q2 25 | 17.8% | -19.9% | ||
| Q1 25 | 18.0% | 3.5% | ||
| Q4 24 | 79.2% | -17.8% | ||
| Q3 24 | 29.1% | 8.7% | ||
| Q2 24 | 21.6% | 34.5% | ||
| Q1 24 | 19.2% | 5.4% |
| Q4 25 | 11.0% | 2.0% | ||
| Q3 25 | 2.4% | 0.1% | ||
| Q2 25 | 2.3% | 0.7% | ||
| Q1 25 | 5.2% | 0.5% | ||
| Q4 24 | 16.9% | 1.3% | ||
| Q3 24 | 4.9% | 0.8% | ||
| Q2 24 | 3.3% | 1.6% | ||
| Q1 24 | 2.4% | 1.3% |
| Q4 25 | 4.10× | 3.66× | ||
| Q3 25 | 0.86× | -1.63× | ||
| Q2 25 | 1.01× | -3.39× | ||
| Q1 25 | 1.15× | 0.09× | ||
| Q4 24 | 4.63× | -1.12× | ||
| Q3 24 | 2.80× | 1.77× | ||
| Q2 24 | 1.41× | 1.04× | ||
| Q1 24 | 1.22× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FMNB
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
